Abstract
FLT4 represents a recently cloned member of class III receptor tyrosine kinases which include receptors for the angiogenic growth factor VEGF, namely FLT1 and KDR. The ligand of FLT4 has been identified as VEGF-C which shares sequence homology with VEGF and P1GF. In the adult FLT4 shows a restricted expression pattern that is limited to lymphatic endothelia and endothelia of some high endothelial venules (HEV). FLT4 has also been detected in some tumor cell lines including the hematopoietic line HEL. We therefore investigated expression of FLT4 and its ligand VEGF-C in fresh samples from patients with AML. Using a sensitive PCR method we detected FLT4 m-RNA in 15 of 41 patients with de novo AML at diagnosis or relapse and in three of 12 patients with secondary AML. FLT4 expression was confirmed by immunocytochemistry in a subgroup of the studied patient population. FLT4 was also found in leukemic cell line U937, but not TF-1 and KG1a. VEGF-C expression was found in leukemic samples of four of seven FLT4-positive and four of six FLT4-negative patients. U937 cells also produced VEGF-C m-RNA. Interestingly, FLT4 expression was not detected in bone marrow samples of 15 normal volunteer donors or in CD34-positive cells from three additional donors. Possible autocrine and paracrine growth stimulation of leukemic blasts by VEGF-C is currently being investigated in our laboratory.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fielder, W., Graeven, U., Ergün, S. et al. Expression of FLT4 and its ligand VEGF-C in acute myeloid leukemia. Leukemia 11, 1234–1237 (1997). https://doi.org/10.1038/sj.leu.2400722
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2400722
Keywords
This article is cited by
-
(Lymph)angiogenic influences on hematopoietic cells in acute myeloid leukemia
Experimental & Molecular Medicine (2014)
-
Vascular endothelial growth factor signaling in acute myeloid leukemia
Cellular and Molecular Life Sciences (2013)
-
A VEGFR-3 Antagonist Increases IFN-γ Expression on Low Functioning NK Cells in Acute Myeloid Leukemia
Journal of Clinical Immunology (2013)
-
DNA methylation regulates expression of VEGF-R2 (KDR) and VEGF-R3 (FLT4)
BMC Cancer (2012)
-
Vascular endothelial growth factor-C and its receptor type-3 expressed in acute lymphocytic leukemia cases with t(1;19)
International Journal of Hematology (2011)